Market revenue in 2022 | USD 74.7 million |
Market revenue in 2030 | USD 152.2 million |
Growth rate | 9.3% (CAGR from 2022 to 2030) |
Largest segment | Sensors |
Fastest growing segment | Insulin Pumps |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Sensors, Transmitter & Receiver, Insulin Pumps |
Key market players worldwide | DexCom Inc, Abbott Laboratories, Medtronic PLC, Ypsomed Holding AG, Senseonics Holdings Inc, A.Menarini Diagnostics, Signos |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to continuous glucose monitoring devices market will help companies and investors design strategic landscapes.
Sensors was the largest segment with a revenue share of 35.34% in 2022. Horizon Databook has segmented the Australia continuous glucose monitoring devices market based on sensors, transmitter & receiver, insulin pumps covering the revenue growth of each sub-segment from 2018 to 2030.
According to the Diabetes Australia, diabetes is one of the fastest-growing chronic disorders in Australia, growing faster than other chronic disorders, such as cardiovascular diseases and cancer. The occurrence of diabetes in children and young adults is increasing.
Moreover, the increasing incidence of newly diagnosed type 1 & 2 diabetes cases is mainly attributed to obesity, unhealthy diet, and physical inactivity. This is expected to increase the healthcare expenditure in developed countries and improve the demand for diabetic care devices.
Manufacturers are leveraging the trend by focusing on developing advanced, technologically innovative products to capture a larger share of the market. In addition, the prevalence of diabetes is on the rise, which is driving the adoption of CGM devices.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia continuous glucose monitoring devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia continuous glucose monitoring devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account